Skip to content
Loading your account…

AZN ASTRAZENECA PLC

NYSEHealth carePharmaceutical PreparationsCambridgeFY ends December 31

This company has no annual 10-K financial data in SEC EDGAR's XBRL facts (for example, foreign issuers that file Form 20-F, funds, or very small filers). Its filings are listed below.

About ASTRAZENECA PLC

Overview

ASTRAZENECA PLC (AZN) is listed on NYSE; the SEC classifies it under "Pharmaceutical Preparations".

Fiscal years shown
—
Latest 10-K
—
Latest filing
6-KNov 2, 2026
SEC EDGAR

Filing timeline

SIC 2834 · Pharmaceutical Preparations

Peers (same SIC code)

Peers (same SIC code)
TickerRevenue (FY)YoYNet marginROEF-Score5y revenue
JNJJOHNSON & JOHNSON$94.2B—28.5%———
LLYELI LILLY & Co$65.2B—31.7%———
MRKMerck & Co., Inc.$65B—28.1%———
ABBVAbbVie Inc.$61.2B—6.9%———
AZNASTRAZENECA PLC (This company)——————
NVSNOVARTIS AG——————
Peer median$65.1B—28.3%———

Companies with the same 4-digit SIC code, ordered by latest revenue. The median excludes this company. — = not reported or not computable.

Frequently asked questions

What does ASTRAZENECA PLC do?

The SEC classifies ASTRAZENECA PLC under Standard Industrial Classification (SIC) code 2834, "Pharmaceutical Preparations". It is headquartered in Cambridge. It is incorporated in United Kingdom.

Where is ASTRAZENECA PLC listed?

According to the SEC, ASTRAZENECA PLC's ticker AZN is listed on NYSE.

When does ASTRAZENECA PLC's fiscal year end?

According to the SEC, ASTRAZENECA PLC's fiscal year ends on December 31.

Source: SEC EDGAR · Last updated:

Ver en español

Not investment advice: This page shows financial data that companies reported to the US Securities and Exchange Commission, for information only. It is not investment advice or a recommendation to buy or sell any security, and it shows no stock prices. Data may be incomplete, restated or out of date — check the original filings on SEC EDGAR before making decisions.